<p>随着年末的临近，主要的美国股票指数连续三个交易日小幅下跌，反映出市场的持续波动和投资者的谨慎。在这样的时期，识别有前景的投资机会可能既具挑战性又富有回报。尽管历史上有负面含义，便士股票仍然通过突出那些尚未被大型投资者关注的小型或新兴公司而提供潜在价值。通过关注那些财务状况良好且有明确增长路径的公司，投资者可以在这个常被忽视的市场细分中发现机会。</p>
<h3>美国十大便士股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>Dingdong (Cayman) (DDL)</td>
<td>$2.49</td>
<td>$574.34M</td>
<td>✅ 4 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>Waterdrop (WDH)</td>
<td>$1.89</td>
<td>$679.93M</td>
<td>✅ 4 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>WM Technology (MAPS)</td>
<td>$0.8343</td>
<td>$142.68M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>LexinFintech Holdings (LX)</td>
<td>$3.29</td>
<td>$553.59M</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Tuya (TUYA)</td>
<td>$2.14</td>
<td>$1.29B</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>CI&amp;T (CINT)</td>
<td>$4.24</td>
<td>$556.91M</td>
<td>✅ 5 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>Golden Growers Cooperative (GGRO.U)</td>
<td>$5.00</td>
<td>$77.45M</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>Nephros (NEPH)</td>
<td>$4.72</td>
<td>$50.16M</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>BAB (BABB)</td>
<td>$0.98</td>
<td>$7.12M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Lifetime Brands (LCUT)</td>
<td>$3.97</td>
<td>$89.94M</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
</tbody>
</table>
<p>点击这里查看我们美国便士股票筛选器中的 341 只股票的完整列表。</p>
<p>让我们更仔细地看看我们从筛选公司中挑选的几只股票。</p>
<h2>Cricut (CRCT)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Cricut, Inc. 设计、营销和分销一个创意平台，帮助用户在全球各个地区创建专业外观的手工商品，市值约为 10.6 亿美元。</p>
<p><strong>运营：</strong> 公司的收入主要来自其平台部门，产生了 3.2283 亿美元的收入。</p>
<p><strong>市值：</strong> 10.6 亿美元</p>
<p>Cricut, Inc. 展示了强健的财务状况，没有债务，短期资产覆盖负债良好。最近的收益显示，2025 年第三季度净收入增加至 2051 万美元，较去年增长 30%，超过行业平均水平。尽管股本回报率高达 22.6%，但由于自由现金流覆盖不足，Cricut 的股息可持续性受到质疑。股票回购表明了股东价值的倡议，而稳定的每周波动性则表明在市场波动中表现一致。然而，过去五年的收益年均下降 24.1%，突显出潜在的长期挑战。</p>
<ul>
<li>点击这里访问我们的完整财务健康分析报告，以了解 Cricut 的动态。</li>
<li>通过我们的公司收益预估报告，获取 Cricut 的前景和预期表现的见解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/69398356-a3da-47e9-8ba3-988efc8c2284/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/69398356-a3da-47e9-8ba3-988efc8c2284/chart/financial-position-analysis"/></p>
<p>截至 2025 年 12 月的 CRCT 财务状况分析</p>
<h2>SOPHiA GENETICS (SOPH)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> SOPHiA GENETICS SA 是一家专注于医疗保健领域的云原生软件技术公司，市值为 3.2092 亿美元。</p>
<p><strong>运营：</strong> 公司的收入主要来自其医疗保健软件部门，总计 7330 万美元。</p>
<p><strong>市值：</strong> 3.2092 亿美元</p>
<p>SOPHiA GENETICS，市值为 3.2092 亿美元，专注于医疗保健软件，在便士股票领域中占有一席之地。尽管处于亏损状态，并且近年来净亏损有所增加，但其收入增长速度快于行业平均水平，预计年增长率为 17.6%。最近的合作，如与 Complete Genomics 在精准肿瘤学测试方面的合作，以及与日本的 A.D.A.A.M Innovations 在液体活检应用方面的合作，突显了其向新市场的战略扩展。该公司保持足够的现金流以覆盖负债，并且尽管股价波动较大，但最近并未出现显著的股东稀释。</p>
<ul>
<li>在这份财务健康报告中解锁我们对 SOPHiA GENETICS 股票分析的全面见解。</li>
<li>通过我们的详细增长报告评估 SOPHiA GENETICS 未来的收益预估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/259cc674-c3b8-4e36-b4e3-60d0d9d9b758/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/259cc674-c3b8-4e36-b4e3-60d0d9d9b758/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 12 月的 SOPH 债务与股本历史及分析</p>
<h2>VTEX (VTEX)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> VTEX 及其子公司为企业品牌和零售商提供软件即服务的数字商务平台，市值为 6.6099 亿美元。</p>
<p><strong>运营：</strong> 该公司从其互联网软件与服务部门产生了 2.3412 亿美元的收入。</p>
<p><strong>市值：</strong> 6.6099 亿美元</p>
<p>VTEX，市值为 6.6099 亿美元，在便士股票领域中脱颖而出，保持盈利并从其数字商务平台中产生 2.3412 亿美元的年收入。该公司无债务，财务健康良好，短期资产显著超过负债。尽管最近一次性损失影响了收益，VTEX 的净收入在 2025 年第三季度从前一年的 337 万美元增长至 635 万美元，反映出稳定的增长。最近的战略举措包括完成价值 2759 万美元的股票回购，并为即将到来的季度和 2025 年全年的收入提供乐观的指导。</p>
<ul>
<li>在我们的财务健康报告中更仔细地看看 VTEX 的潜力。</li>
<li>通过访问我们的收益增长报告评估 VTEX 的前景。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9226b21a-fa0f-4ce2-b8a8-0239eb09b3db/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9226b21a-fa0f-4ce2-b8a8-0239eb09b3db/chart/financial-position-analysis"/></p>
<p>截至 2025 年 12 月的 VTEX 财务状况分析</p>
<h2>将想法转化为行动</h2>
<ul>
<li>通过我们的筛选器深入了解所有 341 只美国便士股票。</li>
<li>想探索一些替代方案吗？我们发现了 13 只预计明年将支付超过 6% 股息收益率的美国股票。查看完整列表，免费获取。</li>
</ul>
<p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
<p>国防与灾难的移动基础设施</p>
<p>下一波机器人技术不是类人型的。它是完全自主的塔楼，在 30 分钟内提供 5G、ISR 和雷达服务，随时随地。</p>
<p>在下一轮合同之前获取投资者简报</p>
<p>代表 CiTech 赞助</p>

VTEX

CRCT

<p>随着美国股指面临下跌，低价股呈现出投资机会。值得关注的股票包括 Cricut、SOPHiA GENETICS 和 VTEX，它们各自拥有强劲的财务状况和增长潜力。Cricut 的市值为 10.6 亿美元，净收入增长 30%，但面临长期挑战。SOPHiA GENETICS 的市值为 3.2092 亿美元，虽然尚未盈利，但收入增长迅速。VTEX 的市值为 6.6099 亿美元，保持盈利且财务健康，收入指引乐观。这些股票突显了尽管整体市场波动，低价股市场的潜力</p>

<p>As the year draws to a close, major U.S. stock indexes have seen slight declines for three consecutive sessions, reflecting ongoing market volatility and investor caution. In such times, identifying promising investment opportunities can be challenging yet rewarding. Penny stocks, despite their historical connotations, continue to offer potential value by highlighting smaller or emerging companies that may not yet be on the radar of larger investors. By focusing on those with strong financials and a clear path to growth, investors can uncover opportunities in this often-overlooked segment of the market.</p>
<div class="lb-trans"><p>随着年末的临近，主要的美国股票指数连续三个交易日小幅下跌，反映出市场的持续波动和投资者的谨慎。在这样的时期，识别有前景的投资机会可能既具挑战性又富有回报。尽管历史上有负面含义，便士股票仍然通过突出那些尚未被大型投资者关注的小型或新兴公司而提供潜在价值。通过关注那些财务状况良好且有明确增长路径的公司，投资者可以在这个常被忽视的市场细分中发现机会。</p>
</div><h3>Top 10 Penny Stocks In The United States</h3>
<div class="lb-trans"><h3>美国十大便士股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>Dingdong (Cayman) (DDL)</td>
<td>$2.49</td>
<td>$574.34M</td>
<td>✅ 4 ⚠️ 0 View Analysis &gt;</td>
</tr>
<tr>
<td>Waterdrop (WDH)</td>
<td>$1.89</td>
<td>$679.93M</td>
<td>✅ 4 ⚠️ 0 View Analysis &gt;</td>
</tr>
<tr>
<td>WM Technology (MAPS)</td>
<td>$0.8343</td>
<td>$142.68M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>LexinFintech Holdings (LX)</td>
<td>$3.29</td>
<td>$553.59M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Tuya (TUYA)</td>
<td>$2.14</td>
<td>$1.29B</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>CI&amp;T (CINT)</td>
<td>$4.24</td>
<td>$556.91M</td>
<td>✅ 5 ⚠️ 0 View Analysis &gt;</td>
</tr>
<tr>
<td>Golden Growers Cooperative (GGRO.U)</td>
<td>$5.00</td>
<td>$77.45M</td>
<td>✅ 2 ⚠️ 5 View Analysis &gt;</td>
</tr>
<tr>
<td>Nephros (NEPH)</td>
<td>$4.72</td>
<td>$50.16M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>BAB (BABB)</td>
<td>$0.98</td>
<td>$7.12M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Lifetime Brands (LCUT)</td>
<td>$3.97</td>
<td>$89.94M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>Dingdong (Cayman) (DDL)</td>
<td>$2.49</td>
<td>$574.34M</td>
<td>✅ 4 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>Waterdrop (WDH)</td>
<td>$1.89</td>
<td>$679.93M</td>
<td>✅ 4 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>WM Technology (MAPS)</td>
<td>$0.8343</td>
<td>$142.68M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>LexinFintech Holdings (LX)</td>
<td>$3.29</td>
<td>$553.59M</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Tuya (TUYA)</td>
<td>$2.14</td>
<td>$1.29B</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>CI&amp;T (CINT)</td>
<td>$4.24</td>
<td>$556.91M</td>
<td>✅ 5 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>Golden Growers Cooperative (GGRO.U)</td>
<td>$5.00</td>
<td>$77.45M</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>Nephros (NEPH)</td>
<td>$4.72</td>
<td>$50.16M</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>BAB (BABB)</td>
<td>$0.98</td>
<td>$7.12M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Lifetime Brands (LCUT)</td>
<td>$3.97</td>
<td>$89.94M</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 341 stocks from our US Penny Stocks screener.</p>
<div class="lb-trans"><p>点击这里查看我们美国便士股票筛选器中的 341 只股票的完整列表。</p>
</div><p>Let's take a closer look at a couple of our picks from the screened companies.</p>
<div class="lb-trans"><p>让我们更仔细地看看我们从筛选公司中挑选的几只股票。</p>
</div><h2>Cricut (CRCT)</h2>
<div class="lb-trans"><h2>Cricut (CRCT)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Cricut, Inc. designs, markets, and distributes a creativity platform that helps users create professional-looking handmade goods across various regions globally, with a market cap of approximately $1.06 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Cricut, Inc. 设计、营销和分销一个创意平台，帮助用户在全球各个地区创建专业外观的手工商品，市值约为 10.6 亿美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily derived from its platform segment, generating $322.83 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入主要来自其平台部门，产生了 3.2283 亿美元的收入。</p>
</div><p><strong>Market Cap:</strong> $1.06B</p>
<div class="lb-trans"><p><strong>市值：</strong> 10.6 亿美元</p>
</div><p>Cricut, Inc. has demonstrated a robust financial standing with no debt and strong short-term asset coverage over liabilities. Recent earnings show an increase in net income to US$20.51 million for Q3 2025, reflecting a significant growth of 30% from the previous year, surpassing industry averages. Despite a high Return on Equity at 22.6%, Cricut's dividend sustainability is questionable due to inadequate free cash flow coverage. Share repurchases indicate shareholder value initiatives, while stable weekly volatility suggests consistent performance amidst market fluctuations. However, past five-year earnings have declined annually by 24.1%, highlighting potential long-term challenges.</p>
<div class="lb-trans"><p>Cricut, Inc. 展示了强健的财务状况，没有债务，短期资产覆盖负债良好。最近的收益显示，2025 年第三季度净收入增加至 2051 万美元，较去年增长 30%，超过行业平均水平。尽管股本回报率高达 22.6%，但由于自由现金流覆盖不足，Cricut 的股息可持续性受到质疑。股票回购表明了股东价值的倡议，而稳定的每周波动性则表明在市场波动中表现一致。然而，过去五年的收益年均下降 24.1%，突显出潜在的长期挑战。</p>
</div><ul>
<li>Click here and access our complete financial health analysis report to understand the dynamics of Cricut.</li>
<li>Gain insights into Cricut's outlook and expected performance with our report on the company's earnings estimates.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里访问我们的完整财务健康分析报告，以了解 Cricut 的动态。</li>
<li>通过我们的公司收益预估报告，获取 Cricut 的前景和预期表现的见解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/69398356-a3da-47e9-8ba3-988efc8c2284/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/69398356-a3da-47e9-8ba3-988efc8c2284/chart/financial-position-analysis"/></p>
<p>CRCT Financial Position Analysis as at Dec 2025</p>
<div class="lb-trans"><p>截至 2025 年 12 月的 CRCT 财务状况分析</p>
</div><h2>SOPHiA GENETICS (SOPH)</h2>
<div class="lb-trans"><h2>SOPHiA GENETICS (SOPH)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> SOPHiA GENETICS SA is a cloud-native software technology company focused on the healthcare sector, with a market cap of $320.92 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> SOPHiA GENETICS SA 是一家专注于医疗保健领域的云原生软件技术公司，市值为 3.2092 亿美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily derived from its healthcare software segment, totaling $73.30 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入主要来自其医疗保健软件部门，总计 7330 万美元。</p>
</div><p><strong>Market Cap:</strong> $320.92M</p>
<div class="lb-trans"><p><strong>市值：</strong> 3.2092 亿美元</p>
</div><p>SOPHiA GENETICS, with a market cap of US$320.92 million, is navigating the penny stock landscape with a focus on healthcare software. Despite being unprofitable and reporting increased net losses over recent years, its revenue is growing faster than the industry average, projected to rise 17.6% annually. Recent collaborations, like those with Complete Genomics for precision oncology testing and A.D.A.A.M Innovations in Japan for liquid biopsy applications, highlight strategic expansions into new markets. The company maintains sufficient cash runway to cover liabilities and has not seen significant shareholder dilution recently despite high share price volatility.</p>
<div class="lb-trans"><p>SOPHiA GENETICS，市值为 3.2092 亿美元，专注于医疗保健软件，在便士股票领域中占有一席之地。尽管处于亏损状态，并且近年来净亏损有所增加，但其收入增长速度快于行业平均水平，预计年增长率为 17.6%。最近的合作，如与 Complete Genomics 在精准肿瘤学测试方面的合作，以及与日本的 A.D.A.A.M Innovations 在液体活检应用方面的合作，突显了其向新市场的战略扩展。该公司保持足够的现金流以覆盖负债，并且尽管股价波动较大，但最近并未出现显著的股东稀释。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of SOPHiA GENETICS stock in this financial health report.</li>
<li>Assess SOPHiA GENETICS' future earnings estimates with our detailed growth reports.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这份财务健康报告中解锁我们对 SOPHiA GENETICS 股票分析的全面见解。</li>
<li>通过我们的详细增长报告评估 SOPHiA GENETICS 未来的收益预估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/259cc674-c3b8-4e36-b4e3-60d0d9d9b758/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/259cc674-c3b8-4e36-b4e3-60d0d9d9b758/chart/debt-equity-history-analysis"/></p>
<p>SOPH Debt to Equity History and Analysis as at Dec 2025</p>
<div class="lb-trans"><p>截至 2025 年 12 月的 SOPH 债务与股本历史及分析</p>
</div><h2>VTEX (VTEX)</h2>
<div class="lb-trans"><h2>VTEX (VTEX)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> VTEX, along with its subsidiaries, offers a software-as-a-service digital commerce platform for enterprise brands and retailers, with a market cap of $660.99 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> VTEX 及其子公司为企业品牌和零售商提供软件即服务的数字商务平台，市值为 6.6099 亿美元。</p>
</div><p><strong>Operations:</strong> The company generates $234.12 million in revenue from its Internet Software &amp; Services segment.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司从其互联网软件与服务部门产生了 2.3412 亿美元的收入。</p>
</div><p><strong>Market Cap:</strong> $660.99M</p>
<div class="lb-trans"><p><strong>市值：</strong> 6.6099 亿美元</p>
</div><p>VTEX, with a market cap of US$660.99 million, stands out in the penny stock realm by maintaining profitability and generating US$234.12 million in annual revenue from its digital commerce platform. The company is debt-free and has strong financial health, with short-term assets significantly exceeding liabilities. Despite a recent one-off loss impacting earnings, VTEX's net income grew to US$6.35 million for Q3 2025 from US$3.37 million a year prior, reflecting steady growth. Recent strategic moves include completing a share buyback worth $27.59 million and providing optimistic revenue guidance for the upcoming quarter and full year 2025.</p>
<div class="lb-trans"><p>VTEX，市值为 6.6099 亿美元，在便士股票领域中脱颖而出，保持盈利并从其数字商务平台中产生 2.3412 亿美元的年收入。该公司无债务，财务健康良好，短期资产显著超过负债。尽管最近一次性损失影响了收益，VTEX 的净收入在 2025 年第三季度从前一年的 337 万美元增长至 635 万美元，反映出稳定的增长。最近的战略举措包括完成价值 2759 万美元的股票回购，并为即将到来的季度和 2025 年全年的收入提供乐观的指导。</p>
</div><ul>
<li>Take a closer look at VTEX's potential here in our financial health report.</li>
<li>Evaluate VTEX's prospects by accessing our earnings growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我们的财务健康报告中更仔细地看看 VTEX 的潜力。</li>
<li>通过访问我们的收益增长报告评估 VTEX 的前景。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9226b21a-fa0f-4ce2-b8a8-0239eb09b3db/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/9226b21a-fa0f-4ce2-b8a8-0239eb09b3db/chart/financial-position-analysis"/></p>
<p>VTEX Financial Position Analysis as at Dec 2025</p>
<div class="lb-trans"><p>截至 2025 年 12 月的 VTEX 财务状况分析</p>
</div><h2>Turning Ideas Into Actions</h2>
<div class="lb-trans"><h2>将想法转化为行动</h2>
</div><ul>
<li>Get an in-depth perspective on all 341 US Penny Stocks by using our screener here.</li>
<li>Want To Explore Some Alternatives? We've found 13 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过我们的筛选器深入了解所有 341 只美国便士股票。</li>
<li>想探索一些替代方案吗？我们发现了 13 只预计明年将支付超过 6% 股息收益率的美国股票。查看完整列表，免费获取。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>国防与灾难的移动基础设施</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波机器人技术不是类人型的。它是完全自主的塔楼，在 30 分钟内提供 5G、ISR 和雷达服务，随时随地。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一轮合同之前获取投资者简报</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>代表 CiTech 赞助</p>
</div>

3 只市值低于 20 亿美元的有潜力的便士股